VIEKIRA XR FDA approval date

The FDA approved VIEKIRA XR on 22 Jul 2016.

FDA approval date
22 Jul 2016

Drug identity has not yet been verified against registry records

Also recorded as DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2016-07-22DayVIEKIRA XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA208624", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["VIEKIRA XR"], "active_ingredients": ["DASABUVIR SODIUM", "OMBITASVIR", "PARITAPREVIR", "RITONAVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160722", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026